BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38712522)

  • 1. ROS-responsive thermosensitive polypeptide hydrogels for localized drug delivery and improved tumor chemoimmunotherapy.
    Li F; Ding J; Li Z; Rong Y; He C; Chen X
    Biomater Sci; 2024 Jun; 12(12):3100-3111. PubMed ID: 38712522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy.
    Wu X; Wu Y; Ye H; Yu S; He C; Chen X
    J Control Release; 2017 Jun; 255():81-93. PubMed ID: 28408199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
    Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of an Injectable Polypeptide Hydrogel Depot Containing the Immune Checkpoint Blocker Anti-PD-L1 and Doxorubicin to Enhance Antitumor Combination Therapy.
    Shi Y; Li D; He C; Chen X
    Macromol Biosci; 2021 Jun; 21(6):e2100049. PubMed ID: 33871152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
    Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
    Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel.
    Huang Z; Xiao H; Lu X; Yan W; Ji Z
    Int J Nanomedicine; 2018; 13():7623-7631. PubMed ID: 30538447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel.
    Jin H; Wan C; Zou Z; Zhao G; Zhang L; Geng Y; Chen T; Huang A; Jiang F; Feng JP; Lovell JF; Chen J; Wu G; Yang K
    ACS Nano; 2018 Apr; 12(4):3295-3310. PubMed ID: 29558107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized controlled release of bevacizumab and doxorubicin by thermo-sensitive hydrogel for normalization of tumor vasculature and to enhance the efficacy of chemotherapy.
    Darge HF; Andrgie AT; Hanurry EY; Birhan YS; Mekonnen TW; Chou HY; Hsu WH; Lai JY; Lin SY; Tsai HC
    Int J Pharm; 2019 Dec; 572():118799. PubMed ID: 31678386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable polypeptide-engineered hydrogel depot for amplifying the anti-tumor immune effect induced by chemo-photothermal therapy.
    Hou XL; Dai X; Yang J; Zhang B; Zhao DH; Li CQ; Yin ZY; Zhao YD; Liu B
    J Mater Chem B; 2020 Sep; 8(37):8623-8633. PubMed ID: 32821893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart pH-Responsive Nanocube-Controlled Delivery of DNA Vaccine and Chemotherapeutic Drugs for Chemoimmunotherapy.
    Duong HTT; Thambi T; Yin Y; Lee JE; Seo YK; Jeong JH; Lee DS
    ACS Appl Mater Interfaces; 2019 Apr; 11(14):13058-13068. PubMed ID: 30888149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An injectable hydrogel with pH-sensitive and self-healing properties based on 4armPEGDA and N-carboxyethyl chitosan for local treatment of hepatocellular carcinoma.
    Zhan J; Wu Y; Wang H; Liu J; Ma Q; Xiao K; Li Z; Li J; Luo F; Tan H
    Int J Biol Macromol; 2020 Nov; 163():1208-1222. PubMed ID: 32645496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injectable hydrogels for the sustained delivery of a HER2-targeted antibody for preventing local relapse of HER2+ breast cancer after breast-conserving surgery.
    Chen X; Wang M; Yang X; Wang Y; Yu L; Sun J; Ding J
    Theranostics; 2019; 9(21):6080-6098. PubMed ID: 31534538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy.
    Jiang M; Chen W; Yu W; Xu Z; Liu X; Jia Q; Guan X; Zhang W
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43963-43974. PubMed ID: 34506118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular hydrogels as a universal scaffold for stepwise delivering Dox and Dox/cisplatin loaded block copolymer micelles.
    Zhu W; Li Y; Liu L; Chen Y; Xi F
    Int J Pharm; 2012 Nov; 437(1-2):11-9. PubMed ID: 22902390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
    Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
    J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion.
    Chen CH; Kuo CY; Chen SH; Mao SH; Chang CY; Shalumon KT; Chen JP
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH triggered injectable amphiphilic hydrogel containing doxorubicin and paclitaxel.
    Zhao L; Zhu L; Liu F; Liu C; Shan-Dan ; Wang Q; Zhang C; Li J; Liu J; Qu X; Yang Z
    Int J Pharm; 2011 May; 410(1-2):83-91. PubMed ID: 21421032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment.
    Yang Z; Yu S; Li D; Gong Y; Zang J; Liu J; Chen X
    Colloids Surf B Biointerfaces; 2018 Dec; 172():387-394. PubMed ID: 30193198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.